Records containing: Sjögren's Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-10-04A Phase II, Randomized, Multi-Center, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Subjects With Moderate to Severe Primary Sjögren's Syndrome
-
CLINICAL_TRIALS study record update · 2018-02-15Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction
-
CLINICAL_TRIALS study record update · 2018-01-19A Biomarker Study to Determine the Gene Expression Signatures of Salivary Gland and Blood in Subjects With Incident Primary Sjögren's Syndrome, Subjects With Sicca, and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2017-05-16Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
-
CLINICAL_TRIALS study record update · 2017-05-11Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome; A Randomised Controlled Pilot Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-08-04Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
-
CLINICAL_TRIALS study record update · 2016-07-29Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome (OCT)
-
CLINICAL_TRIALS study record update · 2016-02-02Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome - A Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2012-09-05A Phase 2, Proof of Concept, 52-Week Open Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Primary Sjögren's Syndrome.
-
CLINICAL_TRIALS study record update · 2012-07-03A Phase 2, Proof of Concept, 52-Week Open Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS (BAFF) Antibody, in Subjects With Primary Sjögren's Syndrome
-
CLINICAL_TRIALS study record update · 2010-08-18Difference in Salivary Flow in Patients With Salivary Gland Hypofunction of the Following Application of Neuro-electrostimulation
-
CLINICAL_TRIALS study record update · 2010-06-28Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2009-04-01Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients: a Prospective Sample Study.